These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34053822)

  • 1. Comparison of the efficacy and safety of levetiracetam and phenytoin in the treatment of established status epilepticus: A systematic review and meta-analysis.
    Yang L; Dong XZ; Cui XH; Liu JM; Liu WN; Zhang L
    J Clin Neurosci; 2021 Jul; 89():422-429. PubMed ID: 34053822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam versus Phenytoin for the Pharmacotherapy of Benzodiazepine-Refractory Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Xue T; Wei L; Shen X; Wang Z; Chen Z; Wang Z
    CNS Drugs; 2020 Dec; 34(12):1205-1215. PubMed ID: 33111213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Angurana SK; Suthar R
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34089322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis.
    Abdelgadir I; Hamud A; Kadri A; Akram S; Pullattayil A; Akobeng AK; Powell C
    Arch Dis Child; 2021 Apr; 106(5):470-476. PubMed ID: 33060105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam versus phenytoin for the treatment of established status epilepticus: A systematic review and meta-analysis of randomized controlled trials.
    Li L; Zhang Y; Jia L; Jia D; Faramand A; Chong W; Fang Y; Ma L; Fang F
    Seizure; 2020 May; 78():43-48. PubMed ID: 32182544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of levetiracetam versus (fos)phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials.
    Feng Y; Chen Y; Jia Y; Wang Z; Wang X; Jiang L; Ai C; Li W; Liu Y
    Seizure; 2021 Oct; 91():339-345. PubMed ID: 34284302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Safety and Effectiveness between Levetiracetam and Phenytoin in the Treatment of Pediatric Status Epilepticus: A Meta- Analysis.
    AlMulihi QA; AlMuhanna FA; AlMuhanna MA; AlSultan EA
    CNS Neurol Disord Drug Targets; 2023; 22(5):745-751. PubMed ID: 35538830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children.
    Naeem B; Ashfaq M; Qureshi MA
    J Ayub Med Coll Abbottabad; 2023; 35(3):410-414. PubMed ID: 38404082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam Versus Phenytoin or Fosphenytoin for Second-Line Treatment of Pediatric Status Epilepticus: A Meta-Analysis.
    Klowak JA; Hewitt M; Catenacci V; Duffett M; Rochwerg B; Jones K; Choong K
    Pediatr Crit Care Med; 2021 Sep; 22(9):e480-e491. PubMed ID: 33710073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis.
    DeMott JM; Slocum GW; Gottlieb M; Peksa GD
    Epilepsy Behav; 2020 Oct; 111():107286. PubMed ID: 32707535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of levetiracetam versus phenytoin as second-line drugs for the treatment of children with convulsive status epilepticus: a Meta analysis].
    Shi R; Yin HQ; Wang ZZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Apr; 23(4):356-362. PubMed ID: 33840407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of benzodiazepine-resistant status epilepticus: Systematic review and network meta-analyses.
    Jain P; Aneja S; Cunningham J; Arya R; Sharma S
    Seizure; 2022 Nov; 102():74-82. PubMed ID: 36209676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin versus levetiracetam as prophylaxis for postcraniotomy seizure in patients with no history of seizures: systematic review and meta-analysis.
    Lee CH; Koo HW; Han SR; Choi CY; Sohn MJ; Lee CH
    J Neurosurg; 2019 Jun; 130(6):2063-2070. PubMed ID: 30004278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.